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EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE
Late referral for assessment of renal failure
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It has been recommended that adult patients with a serum
creatinine above 150 mmol/l should be referred to a
nephrologist for specialist assessment. This study ascertained
all patients in Northern Ireland with creatinine above this
concentration in 2001 (n = 19 286 ) to see if this triggered
referral within the subsequent year. After exclusion of those
who were already known to a nephrologist and those who
had acute renal failure, it was found that younger patients
and diabetic patients were more likely to be referred. There
was no difference in referral rates between male and female
patients. However, only 6.5% of all non-diabetic subjects and
19% of diabetic patients were referred within 12 months
after a first increased serum creatinine test.
I
n the past 20 years, the number of patients receiving
treatment for end stage renal disease (ESRD) has risen
substantially in most developed countries. This trend is
driven by the aging of the population, better recognition of
the outcomes and value of renal replacement therapy, and
increased resources for haemodialysis. Yet data from renal
units point to a pronounced variation in referral of patients
with ESRD.1
The third edition of the Renal Association guidance
suggests that patients should be referred to a specialist, early
in the course of their disease when serum creatinine is
between 150 and 200 mmol/l,2 while the NICE guidance on
the management of type II diabetes recommends referral
when the creatinine reaches 150 mmol/l.3 The impact of using
such thresholds on existing services or on patient outcomes is
unknown. To start such a study and determine the potential
numbers of patients meeting these criteria, we have
capitalised on the comprehensive coverage of the clinical
biochemistry laboratories serving one region’s entire 1.7
million population (Northern Ireland).
METHODS
Our full methods (including details of record linkage
protocols) and the prevalence of chronic kidney disease have
been described elsewhere.4 Briefly, we retrieved data on all
serum creatinine, albumin and urea tests, urinary protein
excretion tests, and HbA1c tests performed in Northern
Ireland laboratories between 1 January 2001 and 31
December 2002. We reduced the test level database to a
relational person level database of patients who had had any
of these tests performed during 2001 and 2002. This analysis
focuses on subjects whose first raised serum creatinine
(above 150 mmol/l) was in 2001.
We were able to define the source and specialty of the
doctor requesting the test and thus could exclude (from the
analysis of subsequent referral rates) those whose first
abnormal test had been ordered by a nephrologist. We
defined a referred case as someone who had had any
subsequent serum creatinine test ordered by a nephrologist
within 12 months of the first abnormal result in 2001. We
excluded those with acute renal failure from the analysis. We
ascertained all deaths through the Office of the Registrar
General and censored subjects on their date of death.
Subjects with acute renal failure were defined as those who
had a creatinine .300 mmol/l in 2001 that returned to
,120 mmol/l within six months of the first raised test.
We defined as diabetic those subjects who had had any
HbA1c test undertaken during the two year period. Results
are presented by age and sex for patients 20 years and over.
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Kaplan-Meier survival estimates (with 95% confidence
limits) were obtained for the proportion referred by
12 months. Cox’s proportional hazards regression was used
to test variation in the referred proportion according to age,
sex, and whether diabetic or not.
The study was approved by the Queens University Medical
Ethics Committee, 2002.
RESULTS
Twenty nine per cent of the resident population had at least
one creatinine test in 2001 and 95% of all tests undertaken
yielded a result below 150 mmol/l (fig 1).
Tables 1 and 2 show that across both sexes and among
diabetic and non-diabetic subjects the proportion ‘‘referred’’
is significantly higher at younger ages.
For example, compared with the oldest age category, 20–39
year olds had a more than fivefold chance of being referred to
a nephrologist (table 2). Overall, less than 20% of diabetic
patients and less than 7% of non-diabetic subjects had a
subsequent investigation undertaken by a nephrologist
within 12 months. Nevertheless the average number of
renal/HbA1c tests performed on each ‘‘non-referred’’ cases
during that period was 20 for diabetic patients and 14 for
non-diabetic subjects (including tests ordered in both
primary and secondary care settings).
DISCUSSION
The feasibility and need for a study such as ours has
previously been highlighted5 but our comparatively static
population in Northern Ireland offers us advantages over
other regions served by more fragmented or dispersed health
services, serving more mobile populations. While our chronic
kidney disease prevalence data are reported elsewhere,4
(based on serum creatinine measurement estimated to be
between 1.56% and 3.25%), it should be borne in mind that
previous estimates from the literature vary according to the
study methodology used. Some earlier studies have been
random population based surveys,6 whereas we have ana-
lysed the data on all subjects who had their creatinine
measured in a particular period. Although we will have
‘‘missed’’ some chronic kidney disease subjects (who did not
have a creatinine test in 2001), you would expect the tested
cohort to be ‘‘enriched’’ with subjects with some sort of
illness (compared with the general population), and thus
more likely to represent those in need of referral. We
excluded 749 cases of presumed acute renal failure. While
these subjects had to survive long enough to have at least a
second creatinine test, whether this misclassifies a compara-
tively small number of acute renal failure and chronic kidney
disease cases is a moot point, for as most of these acute renal
failure cases merit specialist investigation, we do not feel it
bears significantly upon our overall conclusion that existing
renal services in secondary care would have difficulty in
meeting the Renal Association and NICE guidelines.
Previous studies of late referral defined referral delay
according to the interval (greater or less than three months)
between initial referral and the time to dialysis start. Such a
late or ‘‘downstream’’ approach would not truly reflect the
number of people in the general population for whom
interventions may retard progression of kidney disease.
Although not all patients with chronic kidney disease will
progress to ESRD, their increased cardiovascular risk still
offers opportunities for health gain. Undoubtedly, some
patients will die with rather than from their chronic kidney
disease.7
Although we have limited data on how our non-referred
subjects were being managed in primary care (phase II of our
study), we know that fewer than 8% had had additional tests
of renal dysfunction performed (for example an estimate of
the urinary albumin-creatinine ratio or 24 hour urinary
protein excretion).8 The most effective service model for
early intervention is open to question.9 While some modelling
studies show that early referral to a specialist might be cost
effective,10 there is no reason why most of the necessary
intervention could not be delivered by the primary care
team.11 12
In Northern Ireland in 2001 there were about 1100 ESRD
patients receiving renal replacement therapy and 9.5 whole
time equivalent nephrologists saw about 1200 new out-
patients with chronic kidney disease (Korner Statistics,
Table 1 Cumulative risk of referral to a nephrologist within 12 months of initial abnormal
creatinine result*
Age group Number
Cumulative
proportion referred (%)
95% Confidence
limits
Non-diabetic patients 20–39 307 16.6 12.2 to 21.0
40–49 327 16.2 11.7 to 20.6
50–59 806 14.0 11.3 to 16.6
60–69 1746 9.6 8.1 to 11.1
70–79 4094 6.6 5.7 to 7.4
80+ 5689 3.0 2.5 to 3.5
Total 12969 6.5 6.0 to 7.0
Diabetic patients 20–39 74 41.7 31.5 to 51.8
40–49 95 24.9 19.7 to 30.2
50–59 279 26.1 20.8 to 31.5
60–69 801 25.8 22.7 to 29.0
70–79 1392 18.4 16.3 to 20.5
80+ 1075 9.0 7.1 to 10.9
Total 3716 19.2 17.9 to 20.6
*Patients previously known to the nephrology service have been excluded from the denominator.
Table 2 Cox’s proportional hazards regression of effects
of age, sex, and diabetes on proportion referred within
12 months
Comparison Relative hazard
Sex F v M 1.08 (0.98 to 1.20)
Diabetes Yes v No 3.11 (2.81 to 3.43)
Age group 20–39 v 80+ 5.81 (4.54 to 7.44)
40–49 v 80+ 5.31 (4.17 to 6.77)
50–59 v 80+ 3.79 (3.13 to 4.58)
60–69 v 80+ 3.19 (2.72 to 3.74)
70–79 v 80+ 2.21 (1.90 to 2.56)
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KH09, Department of Health and Personal Social Services),
while waiting times were typically less than two to three
months (A P Maxwell, advisor to Regional Review of Renal
Services; personal communication). Although dealing with
many fewer ethnic minority patients (less than 1.0% resident
population), it is otherwise typical (in capacity terms) of
many other UK regions. While there is emerging clinical and
economic evidence for the potential benefits of early referral
to a nephrologist,10 existing renal services in the UK could not
cope with the number of patients with chronic kidney disease
identified in this population based study. New screening,
diagnostic, and treatment strategies are required to integrate
the efforts of primary and secondary care services to improve
the outcomes for people with chronic kidney disease. Failure
to meet the challenge posed by the higher than appreciated
prevalence of chronic kidney disease will result in missed
opportunities for prevention of progressive renal failure. As a
consequence, late referral of more advanced disease requiring
expensive renal replacement therapy will continue to
disadvantage non-diabetic and older patients.
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What this paper adds
Many previous studies have assessed ‘‘late referral’’ as
judged by the (‘‘downstream’’) interval between referral and
the start of dialysis, for patients with chronic kidney disease.
Given the existing Renal Association guidance (that all
patient with creatinine .150 mmol/l should be referred to a
specialist), the novelty of this study is that it has ascertained
the population prevalence of chronic kidney disease and
calculated how many such patients have been referred to a
specialist within 12 months. As early intervention may slow a
decline in renal function, chronic kidney disease abatement
and prevention strategies need to be better informed by this
‘‘upstream’’ approach.
Policy implications
The existing Renal Association guidelines will fail patients,
unless significantly more renal specialists and clinics are
available. Alternatively, improveded primary care manage-
ment of chronic kidney disease or shared care should be
promoted.
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